Vu Quan Anh - Insider Non-Derivative Transactions at Monopar Therapeutics (MNPR) - (SEC)

Updated on March 12, 2026.

According to recent SEC insider information filed on Dec 26, 2025, Vu Quan Anh's relationship to Monopar Therapeutics (MNPR) is Officer (Chief Financial Officer), and currently has 1,500 shares of Common Stock.

The chart below shows the number of shares owned, and the table shows the recent insider transactions.

You can see similar information for other MNPR insiders.

Related Topics: SEC Topic List.

Data Source: SEC.

Vu Quan Anh - Insider Non-Derivative Transactions of MNPR Common Stock

Vu Quan Anh - Insider Non-Derivative Transactions at MNPR

Items per page:

0 of 0

Date	Transaction	No. of Shares	Price Per Share	Shares Owned After Transactions
Dec 27, 2025	P -- (Common Stock)	1500	69.95	1500